Back to News
Market Impact: 0.35
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Source: zacks.com
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Quest Diagnostics beat Q3 earnings and revenue estimates and raised its 2026 outlook, citing strong testing demand and margin gains. Shares nevertheless dipped in pre-market trading; the article provides no figures for the beat, outlook change, or share decline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
DGX0.70
More News
- What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call
- US tech stocks tumble as investors fret over AI spending
- Asian shares wobble as tech rout boosts bonds, dents rate hike bets
- AI debt and French bonds face a stress test — why it may not be over
- Nasdaq 100 Drops as Oil Rise Fuels Risk-Off Mood
- SK Hynix shares slide after chipmaker scraps Solidigm IPO plans